Reconciling Competence and Consent in Opioid-Dependence Research: The Value of Vulnerability Rhetoric

Afolabi, Michael; Sodeke, Stephen O.

doi:10.1080/15265161.2017.1388871

Cited by 3 publications

(2 citation statements)

References 20 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The ability of PWUO to provide informed consent to drug trials has been debated. Although some researchers think PWUO may not be able to provide informed consent due to the belief that addictions control thoughts and behaviors (Afolabi & Sodeke, 2017), others believe that PWUO have the capacity to give informed consent until there is a finding of incapacity (Huang & Wasserman, 2017). Further, assertions that iOAT is an effective medical treatment have attempted to quell concerns about voluntary informed consent and reflects the need to view iOAT as a lifesaving measure for many PWUO who use illicit opioids rather than an ethical debate (Steel et al, 2017).…”

Section: Theme 4: Ethical Considerationsmentioning

confidence: 99%

Injectable opioid agonist treatment: An evolutionary concept analysis

Haines

O’Byrne

2021

Research in Nursing & Health

View full text Add to dashboard Cite

Canada is currently in the midst of an overdose crisis. With new and innovative approaches desperately needed, injectable opioid agonist treatment (iOAT) should be considered as an integral treatment option to prevent even more fatalities. These programs provide injectable diacetylmorphine or hydromorphone to clients with severe opioid use disorders. Currently, they remain an under‐executed and under‐studied treatment modality. To better understand why this may be, we performed an evolutionary concept analysis as described by Rodgers. The attributes, antecedents, consequences, and surrogate terms of iOAT were unpacked and explored. Further, four themes were identified within the literature: (1) physical and mental health, (2) illicit drug use, (3) criminal behavior, and (4) ethical considerations. Recommendations surrounding the need for additional studies that focus on the perspectives of people who use opioids (PWUO), the necessity of nursing advocacy in iOAT, and the consideration of a changing illicit drug supply were explored. Further, theoretical analysis coupled with direct input from PWUO was discussed as a necessity to move forward with iOAT.

show abstract

Section: Theme 4: Ethical Considerationsmentioning

confidence: 99%

Injectable opioid agonist treatment: An evolutionary concept analysis

Haines

O’Byrne

2021

Research in Nursing & Health

View full text Add to dashboard Cite

show abstract

“…We introduced the SMARPP workbook and used it to conceptualize laxative abuse as an addiction. We chose this approach because at the heart of the phenomenon of addiction is the erosion of the desire to refrain from harmful behavior, which is caused by neuroplastic changes in the brain that limit the rational control of such harmful behavior [10]. A clinical examination of the attitude of a patient with AN toward laxative abuse in light of DSM supported our approach.…”

Section: Case Presentationmentioning

confidence: 99%

Controlling the laxative abuse of anorexia nervosa patients with the Serigaya Methamphetamine Relapse Prevention Program workbook: a case report

Toyoshima

Kusumi

2019

BioPsychoSocial Med

View full text Add to dashboard Cite

BackgroundThere is no consensus on effective treatment for laxative abuse in patients with eating disorders. Here, we report the case of a patient with laxative abuse who showed some improvement through an intervention based on the Matrix model.Case presentationA woman diagnosed with anorexia nervosa-binge eating/purging type (AN-BP) steadfastly denied laxative abuse and would not admit to suffering from an eating disorder. This led to low motivation for undergoing conventional psychotherapy, psychoeducation, and cognitive behavioral therapy. These were ineffective and followed by repeated cycles of hospitalization and discharge. The patient’s general condition, as depicted by her laboratory and clinical parameters, deteriorated due to the medical complications resulting from laxative abuse.Focusing on laxative abuse, we considered an intervention for drug addiction. Because the patient could maintain a diet diary and acknowledged laxative abuse as a drug addiction, we introduced the Serigaya Methamphetamine Relapse Prevention Program (SMARPP) workbook as a self-administered treatment. The patient meticulously completed the treatment and experienced a gradual improvement in laxative abuse. She has not been re-hospitalized in 4 years, currently performs household chores, and demonstrates improved social function.ConclusionsIn patients with AN-BP, the SMARPP workbook may be effective in treating laxative abuse.

show abstract